Upcoming Meetings: Emergency research rule
This article was originally published in The Gray Sheet
Executive Summary
Emergency research rule: FDA schedules meeting to discuss the implementation of the Emergency Research Informed Consent Waiver final rule Sept. 29-30 at the Holiday Inn in Bethesda, Maryland. The agency is holding the meeting after researchers requested additional information on implementation procedures. The rule defines the conditions for an exemption from the normal requirements for obtaining informed consent from research subjects. For further information contact FDA's Glen Drew at 301/443-0232...
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.